"Erythrocyte Aging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The senescence of RED BLOOD CELLS. Lacking the organelles that make protein synthesis possible, the mature erythrocyte is incapable of self-repair, reproduction, and carrying out certain functions performed by other cells. This limits the average life span of an erythrocyte to 120 days.
| Descriptor ID |
D004905
|
| MeSH Number(s) |
G04.043.260 G09.188.230
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Erythrocyte Aging".
Below are MeSH descriptors whose meaning is more specific than "Erythrocyte Aging".
This graph shows the total number of publications written about "Erythrocyte Aging" by people in this website by year, and whether "Erythrocyte Aging" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Erythrocyte Aging" by people in Profiles.
-
Nagalla S, Ballas SK. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database Syst Rev. 2018 10 19; 10:CD003426.
-
Nagalla S, Ballas SK. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database Syst Rev. 2016 Mar 04; 3:CD003426.
-
Nagalla S, Ballas SK. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database Syst Rev. 2012 Jul 11; (7):CD003426.
-
Nagalla S, Ballas SK. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database Syst Rev. 2010 Jan 20; (1):CD003426.
-
Chao TL, Berenfeld MR, Gabuzda TG. Current status of methyl acetimidate as an extracorporeal antisickling agent. Am J Pediatr Hematol Oncol. 1984; 6(1):55-8.
-
Gabuzda TG, Chao TL, Berenfeld MR, Gelbart T. In vivo survival studies of 51Cr-labeled methyl acetimidate treated erythrocytes in patients with sickle cell disease. Blood. 1980 Dec; 56(6):1041-7.